Psyence Biomedical (PBM) Competitors $1.30 -0.07 (-5.11%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$1.34 +0.04 (+3.46%) As of 02/21/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends PBM vs. SRZN, PASG, ATNM, VYNE, GRCE, IBIO, RNXT, BIVI, RLYB, and SNYRShould you be buying Psyence Biomedical stock or one of its competitors? The main competitors of Psyence Biomedical include Surrozen (SRZN), Passage Bio (PASG), Actinium Pharmaceuticals (ATNM), VYNE Therapeutics (VYNE), Grace Therapeutics (GRCE), iBio (IBIO), RenovoRx (RNXT), BioVie (BIVI), Rallybio (RLYB), and Synergy CHC Corp. (Uplisting) (SNYR). These companies are all part of the "pharmaceutical products" industry. Psyence Biomedical vs. Surrozen Passage Bio Actinium Pharmaceuticals VYNE Therapeutics Grace Therapeutics iBio RenovoRx BioVie Rallybio Synergy CHC Corp. (Uplisting) Psyence Biomedical (NASDAQ:PBM) and Surrozen (NASDAQ:SRZN) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, profitability, community ranking, valuation, institutional ownership, risk, earnings, media sentiment and analyst recommendations. Does the media refer more to PBM or SRZN? In the previous week, Psyence Biomedical's average media sentiment score of 0.00 equaled Surrozen'saverage media sentiment score. Company Overall Sentiment Psyence Biomedical Neutral Surrozen Neutral Which has better earnings & valuation, PBM or SRZN? Surrozen has higher revenue and earnings than Psyence Biomedical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPsyence BiomedicalN/AN/A-$51.16MN/AN/ASurrozen$10M3.64-$43.04MN/AN/A Does the MarketBeat Community believe in PBM or SRZN? Surrozen received 5 more outperform votes than Psyence Biomedical when rated by MarketBeat users. CompanyUnderperformOutperformPsyence BiomedicalN/AN/ASurrozenOutperform Votes525.00% Underperform Votes1575.00% Is PBM or SRZN more profitable? Psyence Biomedical's return on equity of 0.00% beat Surrozen's return on equity.Company Net Margins Return on Equity Return on Assets Psyence BiomedicalN/A N/A N/A Surrozen N/A -120.51%-54.68% Do analysts rate PBM or SRZN? Surrozen has a consensus target price of $38.50, suggesting a potential upside of 243.75%. Given Surrozen's stronger consensus rating and higher possible upside, analysts clearly believe Surrozen is more favorable than Psyence Biomedical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Psyence Biomedical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Surrozen 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more volatility and risk, PBM or SRZN? Psyence Biomedical has a beta of -0.48, indicating that its stock price is 148% less volatile than the S&P 500. Comparatively, Surrozen has a beta of 0.74, indicating that its stock price is 26% less volatile than the S&P 500. Do institutionals & insiders have more ownership in PBM or SRZN? 77.4% of Psyence Biomedical shares are held by institutional investors. Comparatively, 66.6% of Surrozen shares are held by institutional investors. 3.6% of Psyence Biomedical shares are held by insiders. Comparatively, 43.5% of Surrozen shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. SummarySurrozen beats Psyence Biomedical on 8 of the 11 factors compared between the two stocks. Get Psyence Biomedical News Delivered to You Automatically Sign up to receive the latest news and ratings for PBM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PBM vs. The Competition Export to ExcelMetricPsyence BiomedicalPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.58M$7.04B$5.77B$8.99BDividend YieldN/A2.87%4.78%3.85%P/E RatioN/A5.7325.8218.54Price / SalesN/A312.55453.6679.35Price / CashN/A67.8344.0537.40Price / Book-0.026.747.634.64Net Income-$51.16M$138.11M$3.18B$245.69M7 Day Performance-6.81%-2.54%-1.95%-2.67%1 Month Performance-22.16%-2.00%-0.23%-2.16%1 Year Performance-96.81%-5.04%16.69%12.90% Psyence Biomedical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PBMPsyence BiomedicalN/A$1.30-5.1%N/A-97.0%$9.04MN/A0.00N/ASRZNSurrozen3.0124 of 5 stars$10.00-3.9%$38.50+285.0%-18.2%$36.07M$12.50M0.0080PASGPassage Bio2.5467 of 5 stars$0.57-3.6%$7.75+1,259.4%-57.7%$35.99MN/A0.00130News CoverageATNMActinium Pharmaceuticals1.5292 of 5 stars$1.13+0.9%$7.40+554.9%N/A$35.88M$80,000.000.0030VYNEVYNE Therapeutics2.9774 of 5 stars$2.43+0.8%$6.88+182.9%+26.3%$35.70M$420,000.00-2.8330Analyst ForecastNews CoverageGRCEGrace Therapeutics2.6 of 5 stars$3.51+8.3%N/AN/A$35.59MN/A-3.48N/AAnalyst ForecastAnalyst RevisionNews CoverageGap DownHigh Trading VolumeIBIOiBio0.7421 of 5 stars$3.42-8.1%$4.30+25.7%N/A$35.29M$220,000.000.00100News CoverageRNXTRenovoRx1.9 of 5 stars$1.15-0.9%$9.00+682.6%-24.3%$35.04MN/A0.006BIVIBioVie1.6241 of 5 stars$1.86-3.1%$3.00+61.3%+24.4%$35MN/A-0.1610RLYBRallybio2.4536 of 5 stars$0.78-7.6%$9.75+1,150.0%-58.1%$34.97MN/A0.0040High Trading VolumeSNYRSynergy CHC Corp. (Uplisting)N/A$3.43-10.7%$10.00+191.5%N/A$34.81MN/A0.0040Gap Up Related Companies and Tools Related Companies Surrozen Alternatives Passage Bio Alternatives Actinium Pharmaceuticals Alternatives VYNE Therapeutics Alternatives Grace Therapeutics Alternatives iBio Alternatives RenovoRx Alternatives BioVie Alternatives Rallybio Alternatives Synergy CHC Corp. (Uplisting) Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PBM) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredA strange twist 500 miles from WashingtonEnergy is life. And this year, it could also make national heroes out of President Trump and VP Vance. ...Porter & Company | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Psyence Biomedical Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Psyence Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PBM Stock Alerts